Pharmaceutical & Life Sciences News
View and Filter All Stories

Latest Stories

Drugmaker Mallinckrodt Buys Time for Lawsuits With New Debt Swap

Mallinckrodt Plc, the maker of opioids and other drugs, struck a deal with lenders including hedge fund Aurelius Capital Management and Franklin Advisers that buys it five more years to repay a chunk of its billions in debt, according to a regulatory filing from the company.

View More

Coronavirus Is Changing the Way Lawyers Work

Lawyers from New York City to Seattle tell us how the coronavirus is impacting their work and how they are responding.

Up Next

PFAS: The 'Forever Chemicals'

View More